The 44th Annual J.P. Morgan (JPM) Healthcare Conference in San Francisco is the industry’s most significant gathering of the year. Protheragen, as a catalyst for global pharmaceutical innovation and strategic cross-border partnerships, organized a series of in-depth discussions aimed at promoting cooperation opportunities, successfully concluding the fruitful week.
Protheragen’s delegation maintained a rigorous schedule throughout the week, anchoring their presence at key satellite events, including the renowned Bio Partnering sessions and the prestigious SAPA Investment Forum.
Leveraging an extensive global network, our team facilitated connections between cutting-edge pharmaceutical assets and prospective global partners. We engaged in deep-dive strategic discussions with a diverse array of stakeholders, including:
Who Protheragen Met During JPM Week 2026
“The energy at JPM 2026 confirmed that the appetite for high-quality pharmaceutical assets and strategic collaboration is stronger than ever,” said a spokesperson for Protheragen. “Our team’s ability to precisely match innovative assets with the right global partners allowed us to cut through the noise. We moved beyond introductory pleasantries to discuss deal structures, strategic fit, and long-term value creation. The trust established during these face-to-face interactions is the bedrock upon which successful transactions are built.”
Following a week of productive networking and trust-building, Protheragen has immediately transitioned into the execution phase. We are currently advancing multiple leads generated during the conference. Protheragen remains committed to converting these strategic dialogues into tangible partnerships that accelerate the development of life-saving therapies.
Protheragen is a leading strategic service provider dedicated to connecting innovative pharmaceutical resources with global partners. With a core focus on efficiency and precision, Protheragen facilitates a wide spectrum of strategic collaborations, including asset licensing, equity financing, co-development, and mergers and acquisitions. Backed by a team of seasoned industry veterans and a vast network of global connections, Protheragen empowers clients to navigate the complex pharmaceutical landscape and maximize asset value.
We are eagerly looking forward to communicating with you and explore the possibilities of collaboration. Please feel free to contact us.
Protheragen's business is growing rapidly after founded in New York. Our business has evolved from the initial intermediary service to encompass segments in equity investment and program incubation.
 |
Protheragen Inc. |
 |
Quick Links |